Veracyte VCYT
$25.13 +$0.09 (+0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.18 +0.20%
Open$24.63
Prev close$25.04
Day range$24.53 – $25.60
Volume2.79M
Market cap$2.03B
P/E (TTM)16.3
Dividend yield–
Earnings
Average move on report day±14.0%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+27.5%
Worst reaction-54.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 4 Nov 2026 | After Market | ±15.7% | -54.30% | Bigger than priced |
| 2026/Q2 | 30 Jul 2026 | After Market | ±14.0% | -22.52% | Bigger than priced |
| 2026/Q1 | 5 May 2026 | After Market | ±20.9% | +24.93% | Bigger than priced |
| 2025/Q4 | 25 Feb 2026 | After Market | ±19.8% | +8.48% | Within range |
| 2025/Q3 | 4 Nov 2025 | After Market | ±12.7% | +27.46% | Bigger than priced |
| 2025/Q2 | 6 Aug 2025 | After Market | ±10.7% | +15.48% | Bigger than priced |
| 2025/Q1 | 7 May 2025 | After Market | ±18.8% | +1.20% | Within range |
| 2024/Q4 | 24 Feb 2025 | After Market | ±21.3% | -14.99% | Within range |
| 2024/Q3 | 6 Nov 2024 | After Market | ±13.6% | +2.05% | Within range |
| 2024/Q2 | 6 Aug 2024 | After Market | ±14.2% | +23.97% | Bigger than priced |
| 2024/Q1 | 7 May 2024 | After Market | – | -4.33% | – |
| 2023/Q4 | 22 Feb 2024 | After Market | ±20.8% | -8.87% | Within range |
| 2023/Q3 | 7 Nov 2023 | After Market | ±18.6% | -3.58% | Within range |
| 2023/Q2 | 8 Aug 2023 | After Market | ±24.5% | +7.04% | Within range |
| 2023/Q1 | 4 May 2023 | After Market | ±16.3% | +4.58% | Within range |
| 2022/Q4 | 22 Feb 2023 | After Market | ±20.5% | +0.13% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$151.75M+15.1% YoY
Operating profit$16.57M-27.8% YoY
Net profit$31.50M+64.6% YoY
Diluted EPS$0.38+58.3% YoY
Free cash flow$37.92M-9.6% YoY
Operating cash flow$40.26M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin72.0%
Operating margin17.1%
Net margin21.8%
Return on equity9.4%
Return on assets8.6%
Return on invested capital8.5%
Current ratio5.56
Liabilities / assets8.9%
Cash & investments$370.53M
Total debt$33.92M
Net cash (debt)$336.61M
Free cash flow / sales27.8%
No comments yet — be the first to weigh in on VCYT.
Sign in to join the discussion.